TriFoil Imaging partners with Johns Hopkins University to advance pre-clinical optical imaging applications
University will pursue cancer imaging work using novel 3D capability
Chatsworth, CA— 26th February 2020 — Today, TriFoil Imaging announced an application partnership with the Division of Cancer Imaging Research at Johns Hopkins University.
Under the direction of Dr. Zaver Bhujwalla, Johns Hopkins researchers will use the 360° 3D fluorescence imaging capability in TriFoil's InSyTe FLECT/CT system to develop sophisticated pre-clinical models for cancer research and treatment.
Dr. Bhujwalla said "Using optical modalities deep inside the live mouse will enable us to target, image and investigate both disease mechanisms and treatments for a wide range of cancers."
Aaron McCormack, President & CEO of TriFoil Imaging, said “we are delighted to announce this partnership with Johns Hopkins University and we are confident that full 3D fluorescent imaging can deliver new levels of insight for cancer researchers.”
About TriFoil Imaging
TriFoil Imaging offers the world’s only true 3D optical imaging system for pre-clinical animal applications. Our InSyTe FLECT/CT instrument acquires both CT and fluorescence data in 360°, enabling incredible depth of insight and localization of imaging targets. With over 20-years of selling and supporting molecular imaging systems, TriFoil exists to help pre-clinical researchers to do their best work
###
For more information, press only:
Aaron McCormack aaron.mccormack@trifoilimaging.com